Hypoxia potentiates glioma-mediated immunosuppression.
Glioblastoma multiforme (GBM) is a lethal cancer that exerts potent immune suppression. Hypoxia is a predominant feature of GBM, but it is unclear to the degree in which tumor hypoxia contributes to this tumor-mediated immunosuppression. Utilizing GBM associated cancer stem cells (gCSCs) as a treatm...
Main Authors: | Jun Wei, Adam Wu, Ling-Yuan Kong, Yongtao Wang, Gregory Fuller, Isabella Fokt, Giovanni Melillo, Waldemar Priebe, Amy B Heimberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3024401?pdf=render |
Similar Items
-
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
by: Martina Ott, et al.
Published: (2020-09-01) -
The Controversial Role of Microglia in Malignant Gliomas
by: Jun Wei, et al.
Published: (2013-01-01) -
The content of hypoxia-inducible factors and mediators of immunosuppression in the blood in diseases associated with hypoxia
by: S. P. Chumakova, et al.
Published: (2020-10-01) -
Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
by: Zhe Fu, et al.
Published: (2021-04-01) -
The mechanism of immunosuppression in patients with brain glioma
by: V A Frolov, et al.
Published: (2014-12-01)